Whole cohort (n = 88) | P value | |
---|---|---|
Age (years) | 57 (36–70) | 0.01** |
Gender, men | 52 (59%) | 0.71 |
Body weight (kg) | 54 (48–63) | 0.12* |
Use of steroid before TPE | 72 (77%) | |
Start of steroid use | No steroid on day of TPE | Reference |
The day of TPE | 5 (6%) | 0.15* |
1–7 days before TPE | 24 (27%) | 0.29 |
>7 days before TPE | 39 (44%) | 0.40 |
Prednisolone-equivalent dose on day of TPE (mg/day) | 20 (0.63–60) | 0.63 |
Use of immunosuppressant before TPE | 26 (28%) | 0.04** |
History of allergy | 26 (30%) | 0.47 |
History of blood transfusion | 27 (31%) | 0.07* |
Indication for TPE | ||
ABO-incompatible kidney transplantation | 13 (15%) | Reference |
Hepatic failure | 18 (20%) | 0.01** |
Others | 57 (65%) | 0.11* |
Amount of FFP (units/kg) | 0.69 (0.60–0.75) | 0.14* |
White blood cell count (/μl) | 8850 (5100–13,100) | 0.04** |
Hemoglobin (g/dl) | 8.8 (7.0–10.7) | 0.80 |
Platelet count (103/μl) | 108 (54.5–217.8) | 0.59 |
Serum creatinine (mg/dl) | 2.77 (0.69–6.25) | 0.02** |
Serum albumin (g/dl) | 3.0 (2.6–3.5) | 0.33 |
Serum C-reactive protein (mg/dl) | 1.12 (0.16–4.52) | 0.39 |